- Home
- / Quest Diagnostics
Quest Diagnostics
Volume (Healthcare Insurers), percent
(46.0%)
FY, 2021
Revenue
$10.8 B
FY, 2021
Market Capitalization
$15.4 B
2022-09-19
Quest Diagnostics Summary
Company summary
- Overview
- Quest Diagnostics is a company providing diagnostic testing, information, and other services. It also offers diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its medical and scientific staff, cancer diagnostics, and anatomic pathology services. The company serves patients, healthcare providers, pharmaceutical medical device companies, life insurance companies, and employers.
- Type
- Public
- Founded
- 1967
- HQ
- Secaucus, NJ, US | view all locations
- Cybersecurity rating
- ESG rating
- out of 100 | View all ESG data
Key people
Mark J. Guinan, Executive Vice President and Chief Financial Officer
Cecilia McKenney, Senior Vice President, Chief Human Resources Officer
Gabrielle Wolfson, Senior Vice President, Chief Information and Digital Officer
Operating MetricsView all
Volume (Healthcare Insurers), percent
46.0%
4.5%
FY, 2021
Volume (Government Payers), percent
10.0%
9.1%
FY, 2021
Volume (Client Payers), percent
39.0%
2.5%
FY, 2021
LocationsView all
5 locations detected
Secaucus, NJ HQ
United States
500 Plaza Dr
Santana De Parnaiba, SP
Brazil
1818 Estrada Tenente Marques, A06 & A07
Dublin, County Dublin
Ireland
Block 1, Unit 10, 9 Northwood Ave, Northside
Ciudad de México, CDMX
Mexico
Frontera 4, Roma Nte., Cuauhtémoc
Ciudad de México, CDMX
Mexico
World Trade Center 9th Floor, Office 19 Col. Napoles, Deleg. Benito Juarez
Quest Diagnostics Financials
Summary financials
- Revenue (Q2, 2022)
- $2.5B
- Gross profit (Q2, 2022)
- $842.0M
- Net income (Q2, 2022)
- $250.0M
- Cash (Q2, 2022)
- $790.0M
- EBIT (Q2, 2022)
- $388.0M
- Enterprise value
- $19.3B
